The FDA’s derogation of duty in failing to appropriately regulate fluoride products came to light largely due to a nine-year investigation by the late New Jersey Assemblyman, John Kelly.

Kelly became interested in fluoride after a study from the New Jersey Department of Health found higher rates of osteosarcoma (bone cancer) in adolescent males drinking fluoridated water. Prior to his passing, John Kelly wrote an excellent detailed summary of what he learned through his experience trying to get answers from the FDA and other government institutions about the studies supposedly proving fluoride’s “safety and effectiveness.” To read Kelly’s statement, click here. 

John Kelly’s Letters to FDA & CDC:

• October 30, 2000: Letter to Jeffrey Koplan, Director, CDC
• October 26, 2000: Letter to Jane Henry, Commissioner, FDA
• June 7, 1993: Letter to Frank Fazzari, Chief, Prescription Compliance Branch, FDA
• June 3, 1993: Letter to David Kessler, Commissioner, FDA

See also:

• Letter to David Kennedy – May 26, 1995

Print PDF